Cytoplasmic p63 immunohistochemistry is a useful marker for muscle differentiation: An immunohistochemical and immunoelectron microscopic study

Modern Pathology

Volumn 24, Issue 10, 2011, Pages 1320-1326

  Martin, Sarah E ^a   Temm, Constance J ^a   Goheen, Mike P ^a   Ulbright, Thomas M ^a   Hattab, Eyas M ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

immunoelectron microscopy; immunohistochemistry; p63; rhabdomyosarcoma; skeletal muscle

Indexed keywords

DESMIN; PARAFFIN; PROTEIN P63;

ARTICLE; BLASTOMA; CARCINOGENESIS; CLINICAL ARTICLE; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; LEIOMYOSARCOMA; LUNG TUMOR; MEDULLOMYOBLASTOMA; MUSCLE DEVELOPMENT; NEPHROBLASTOMA; PLEUROPULMONARY BLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHABDOMYOMA; RHABDOMYOSARCOMA; TERATOMA; TUMOR DIFFERENTIATION;

CELL DIFFERENTIATION; CEREBELLAR NEOPLASMS; CYTOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LEIOMYOMA; LEIOMYOSARCOMA; MEDULLOBLASTOMA; MICROSCOPY, IMMUNOELECTRON; MUSCLE, SKELETAL; MUSCLE, SMOOTH; MYOCARDIUM; NEOPLASMS; PULMONARY BLASTOMA; RHABDOMYOSARCOMA; TERATOMA; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; WILMS TUMOR;

EID: 80053563111     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.89     Document Type: Article

References (13)

1. Barbareschi M, Pecciarini L, Cangi MG, et al p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001;25:1054-1060. (Pubitemid 32685903)
2. Shah RB, Zhou M, LeBlanc M, et al Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol 2002;26:1161-1168. (Pubitemid 34969185)
3. Weinstein MH, Signoretti S, Loda M. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Mod Pathol 2002;15:1302-1308. (Pubitemid 35462998)
4. Tacha DE, Miller RT. Use of p63/P504S monoclonal antibody cocktail in immunohistochemical staining of prostate tissue. Appl Immunohistochem Molecul Morphol 2004;12:75-78. (Pubitemid 38332324)
5. Reis-Filho JS, Simpson PT, Martins A, et al Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 2003;443:122-132. (Pubitemid 37056135)
6. Owens SR, Greenson JK. Immunohistochemical staining for p63 is useful in the diagnosis of anal squamous cell carcinomas. Am J Surg Pathol 2007;31:285-290. (Pubitemid 46175030)
7. Koker MM, Kleer CG. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol 2004;28:1506-1512. (Pubitemid 39425518)
8. Lewis JS, Ritter JH, El-Mofty S. Alternative epithelial markers in sarcomatoid carcinomas of the head and neck, lung, and bladder-p63, MOC-31, and TTF-1. Mod Pathol 2005;18:1471-1481. (Pubitemid 41509402)
9. Dickson BC, Li S-Q, Wunder JS, et al Giant cell tumor of bone express p63. Mod Pathol 2008;21:369-375. (Pubitemid 351441039)
10. Lee C-H, Espinosa I, Jensen KC, et al Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone. Mod Pathol 2008;21:531-539. (Pubitemid 351589649)
11. Cam H, Griesmann H, Beitzinger M, et al p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cancer Cell 2006;10:281-293. (Pubitemid 44512191)
12. Ikawa S, Nakagawara A, Ikawa Y. p53 family genes: structural comparison, expression and mutation. [see comment]. Cell Death Differ 1999;6:1154-1161. (Pubitemid 30047891)
13. Yang YG, Makita T. Immunocytochemical localization of desmin in skeletal muscle of swine. J Vet Med Sci 1995;57:475-479.